The invention relates to application of D-
mannose in preparation of products for treating
periodontitis. The products comprise medicines, daily necessities and foods. The D-
mannose provided by the invention can effectively inhibit the alveolar
bone resorption of rats induced by LPS, down-regulate the expression of IL-1beta, IL-6, IL-17, TNF-alpha, G-CSF, GM-CSF, MPO, Ly6G, CD11b, TET2, HK1, HK2 and PFPKB3 in rat gingival tissues treated by the LPS, and up-regulate the expression of IL-10. In addition, the D-
mannose can also inhibit the activation of neutrophil stimulated by LPS, down-regulate the expression of IL-1beta, IL-6, IL-17 and TET2, and up-regulate the expression of IL-10.